3744 results

Editorial: Hypertension and Renal Denervation

20 Sep 2024

Hypertension is the number one cause of years of life lost, and, perhaps more importantly, years of healthy living lost. It causes at least half of all heart attacks and strokes and is the major driver of heart failure.

Author

Andrew Sharp

Celebrating 20 years of EuroIntervention!

22 May 2025

According to Editor-in-Chief, Davide Capodanno, EuroIntervention marks this milestone by continuing its upward trajectory, blending cutting-edge and traditional elements to bring the latest data to its readers faster than ever before.

Author

Davide Capodanno

Future directions of drug-coated balloon angioplasty

06 Feb 2025

Fernando Alfonso and Javier Cuesta discuss the growing role of drug-coated balloons as an alternative to stents in percutaneous coronary interventions. Highlighting advantages like reduced in-stent restenosis, they emphasize the need for robust clinical studies to refine DCB use.

Author

Fernando Alfonso

Author

Javier Cuesta

Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial

29 Mar 2025

Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.

Author

Aaysha Cader

Elixir Medical’s DynamX Bioadaptor demonstrates significant improvement over contemporary drug-eluting stent in patients with acute coronary syndrome and complex lesion subsets after six months

28 Oct 2024

Pi-Cardia reports first commercial cases with ShortCut™

03 Mar 2025

First-in-human data for Sensome clot-sensing guidewire used in ischemic stroke treatment demonstrate ability to automate clot characterization with no safety issues

05 Jun 2024

EuroPCR 2025 – The FAITAVI trial: angiography versus physiology-guided PCI in patients undergoing TAVI – 12-month follow-up data

21 May 2025

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...

Feasibility of sheathless Impella for protected percutaneous coronary intervention: a single-center experience

02 May 2025

Impella CP microaxial flow pump supports complete revascularisation during high-risk PCI, but standard implantation often leads to vascular complications. This article explores an initial experience with a sheathless implantation technique, which shows promise as a feasible and safe alternative.

SMT Announces Completion of Patient Enrolment for TUXEDO-2 Trial

16 Aug 2024

GENESIS-II study reveals promising 30-day results for the hydra self-expanding transcatheter aortic valve

16 May 2024

Pi-Cardia’s ShortCut™ Becomes First Leaflet Modification Technology to Receive CMS NTAP for Valve-in-Valve TAVR

06 Aug 2025

SMT won the Italian National CONSIP 2-Year Tender to Supply Hydra TAVI in All Italian Hospitals

16 Aug 2024

A short history of the Euro4C Group

16 Jan 2019

Who better to recount its history than the inaugural President of the Euro4C Group? Additionally, insights are provided by the Chairman of PCR, the former EAPCI President, and a pivotal member of the editorial team.

Recruitment complete in BEVAR study for on-label use of the Bentley BeGraft peripheral PLUS as a bridging stent

10 Mar 2023

Gore Cardioform ASD occluder implantation for late progression of TR after Triclip

12 Mar 2025

Late progression of TR following T-TEER is not uncommon and may be challenging to treat due to anatomical and technical limitations. This is the 1st report of Gore Cardioform ASD Occluder implantation to treat recurrent severe TR after T-TEER.

Foldax secures approval for TRIA Mitral Heart Valve in India

05 Jun 2025

The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation

01 Sep 2025

Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.

Author

Chiara De Biase

EuroPCR 2025: RESIL-Card achieves a major milestone - The resilience tool is ready for pilot testing!

20 May 2025

Launched in December 2023 by our community through the ‘We CARE Alliance’ and co-funded by the EU4Health work programme, the mission of the RESIL-Card project is to ensure that essential healthcare services for people with cardiovascular (CV) diseases are maintained during crises. Specifically, the project aims to...

Sensome signs exclusive commercial distribution agreement for clot-sensing guidewire In Japan with Cosmotec

10 Jul 2024